HighTower Advisors’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
GIA
BFM
AF
PC
AC
AIM
HighTower Advisors's DRTS Position: Q2 2026 in Review
HighTower Advisors held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 874,994 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #898.
HighTower Advisors first reported a position in DRTS in Q4 2023 and has held it in 11 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- HighTower Advisors held 874,994 shares of Alpha Tau Medical worth $11M as of Q2 2026.
- HighTower Advisors left its Alpha Tau Medical share count unchanged in Q2 2026.
- Alpha Tau Medical made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #898 holding.
- HighTower Advisors first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 11 quarters since.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.